Azapropazone

Azapropazone
Clinical data
Trade names Rheumox
AHFS/Drugs.com International Drug Names
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
Pharmacokinetic data
Elimination half-life 20 hours
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
ECHA InfoCard 100.033.543
Chemical and physical data
Formula C16H20N4O2
Molar mass 300.36 g/mol
3D model (JSmol)
Chirality Racemic mixture
 NY (what is this?)  (verify)

Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID). It is manufactured by Goldshield under the tradename Rheumox.[1]

It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.

Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]

References

  1. http://home.intekom.com/pharm/cont_eth/rheumox.html
  2. http://www.patient.co.uk/showdoc/30002267/
  3. Jones CJ (1976). "The pharmacology and pharmacokinetics of azapropazone - a review". Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.